chrM-4132-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3

This summary comes from the ClinGen Evidence Repository: The m.4132G>A (p.A276T) variant in MT-ND1 was reviewed by the Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel on May 23, 2023. There is one family reported in the medical literature with this variant (PMID:17454741). The six affected individuals in this family had non-arteritic anterior ischemic optic neuropathy. The variant was present at homoplasmy in all affected family members and information is not provided on testing status in unaffected family members, precluding consideration for segregation evidence. There are no other individuals or families with primary mitochondrial disease with this variant reported in the medical literature to our knowledge. This variant is present in population databases and is seen in individuals from several different haplogroups (MITOMAP: 0.015%, 9/61,883; gnomAD v3.1.2: 0.019%, 11/56,428 homoplasmic occurrences; Helix: 0.041%, 80/195,893 homoplasmic occurrences). The computational predictor APOGEE gives a consensus rating of pathogenic with a score of 0.58 (Min=0, Max=1), which predicts a damaging effect on gene function (PP3). There are no cybrids, single fiber studies, or other functional assays reported for this variant. In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on May 23, 2023. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID:32906214): PP3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA16603348/MONDO:0044970/015

Frequency

Mitomap GenBank:
𝑓 0.00010 ( AC: 9 )

Consequence

MT-ND1
ENST00000361390.2 missense

Scores

Apogee2
Benign
0.065

Clinical Significance

Uncertain significance reviewed by expert panel U:2B:1
NAION-associated

Conservation

PhyloP100: 2.65

Publications

1 publications found
Variant links:
Genes affected
MT-ND1 (HGNC:7455): (mitochondrially encoded NADH dehydrogenase 1) Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Located in mitochondrial membrane. Part of mitochondrial respiratory chain complex I. Implicated in several diseases, including MELAS syndrome; neurodegenerative disease (multiple); optic nerve disease (multiple); toxic shock syndrome; and type 2 diabetes mellitus. Biomarker of Alzheimer's disease; Parkinson's disease; and multiple sclerosis. [provided by Alliance of Genome Resources, Apr 2022]
TRNI (HGNC:7488): (mitochondrially encoded tRNA isoleucine)
TRNQ (HGNC:7495): (mitochondrially encoded tRNA glutamine)
TRNQ Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: Mitochondrial Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000361390.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP3
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000361390.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MT-ND1
ENST00000361390.2
TSL:6
c.826G>Ap.Ala276Thr
missense
Exon 1 of 1ENSP00000354687.2P03886
MT-TI
ENST00000387365.1
TSL:6
n.-131G>A
upstream_gene
N/A
MT-TQ
ENST00000387372.1
TSL:6
n.*197C>T
downstream_gene
N/A

Frequencies

Mitomap GenBank
AF:
0.00010
AC:
9
Gnomad homoplasmic
AF:
0.00019
AC:
11
AN:
56433
Gnomad heteroplasmic
AF:
0.0
AC:
0
AN:
56433

Mitomap

Disease(s): NAION-associated
Status: Reported-[VUS]
Publication(s): 17454741

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Leigh syndrome (1)
-
1
-
Mitochondrial disease (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
0.065
Hmtvar
Benign
0.12
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.23
T
DEOGEN2
Benign
0.012
T
LIST_S2
Benign
0.53
T
MutationAssessor
Benign
-1.1
N
PhyloP100
2.6
PROVEAN
Benign
-0.080
N
Sift4G
Uncertain
0.033
D
Varity_R
0.20
Mutation Taster
=59/41
polymorphism

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1057520201;
hg19: chrM-4133;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.